Sjögren

Neurology

17 drugs in development·10 companies·2 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
dazodalibep	AMGEN INC (AMGN)
VAY736	Novartis AG (NVS)

Phase 2(10)

Drug	Company
Abiprubart	Kiniksa Pharmaceuticals International, plc (KNSA)
cfz533	Novartis AG (NVS)
IMVT-1402	Immunovant, Inc. (IMVT)
rapcabtagene autoleucel	Novartis AG (NVS)
rapcabtagene autoleucel	Novartis AG (NVS)
sar441344	Sanofi (SNY)
vay736 1ml pfs	Novartis AG (NVS)
vay736 2 ml pfs	Novartis AG (NVS)
vay736 2ml ai	Novartis AG (NVS)
VELDONA (Sjögren's syndrome)	Ainos Inc. (AIMD)

Phase 1(3)

Drug	Company
CLN-978	Cullinan Therapeutics, Inc. (CGEM)
vay736	Novartis AG (NVS)
vib7734	Viela Bio, Inc. (VIE)

Phase 2/Phase 3(1)

Drug	Company
imvt-1402	Roivant Sciences Ltd. (ROIV)

Phase 4(1)

Drug	Company
Efgartigimod	ARGENX SE (ARGX)

BioSniper tracks 17 drugs in development for Sjögren across 10 companies.

There are 2 clinical trials targeting Sjögren tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.